• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群的研究中评估脂肪肝指数识别非酒精性脂肪肝的外部验证。

External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Hospital, Rotterdam, The Netherlands.

出版信息

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4. doi: 10.1016/j.cgh.2012.12.031. Epub 2013 Jan 22.

DOI:10.1016/j.cgh.2012.12.031
PMID:23353640
Abstract

BACKGROUND & AIMS: We aimed to validate the fatty liver index (FLI), an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase. We calculated its ability to identify fatty liver disease from any cause or nonalcoholic fatty liver disease (NAFLD) in a large population of white elderly persons.

METHODS

We collected ultrasonography and FLI data from participants of the Rotterdam Study from February 2009 to February 2012; 2652 subjects (mean age, 76.3 ± 6.0 years) were interviewed and received a clinical examination that included abdominal ultrasound, analysis of blood samples during fasting, and anthropometric assessment. The ability of the FLI to detect (nonalcoholic) fatty liver was assessed by using area under the receiver operator characteristic (AUROC) curve analysis.

RESULTS

FLI score was associated with NAFLD in multivariable analysis (odds ratio, 1.05; 95% confidence interval [CI], 1.04-1.05; P < .001). FLI identified patients with NAFLD with an AUROC curve of 0.813 (95% CI, 0.797-0.830) and those with fatty liver from any cause with an AUROC curve of 0.807 (95% CI, 0.792-0.823).

CONCLUSIONS

The FLI (an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase) accurately identifies NAFLD, confirmed via ultrasonography, in a large, white, elderly population.

摘要

背景与目的

我们旨在验证脂肪肝指数(FLI),这是一种基于腰围、体重指数和甘油三酯及γ-谷氨酰转移酶水平的算法。我们计算了其在一个白人老年人群中识别任何原因引起的脂肪肝或非酒精性脂肪肝(NAFLD)的能力。

方法

我们从 2009 年 2 月至 2012 年 2 月期间的 Rotterdam 研究参与者中收集了超声和 FLI 数据;对 2652 名受试者(平均年龄 76.3±6.0 岁)进行了访谈,并进行了临床检查,包括腹部超声、空腹血液样本分析和人体测量评估。使用受试者工作特征(ROC)曲线下面积(AUROC)分析评估 FLI 检测(非酒精性)脂肪肝的能力。

结果

多变量分析显示 FLI 评分与 NAFLD 相关(比值比,1.05;95%置信区间 [CI],1.04-1.05;P<.001)。FLI 以 0.813(95%CI,0.797-0.830)的 AUROC 曲线识别出 NAFLD 患者,以 0.807(95%CI,0.792-0.823)的 AUROC 曲线识别出任何原因引起的脂肪肝患者。

结论

FLI(一种基于腰围、体重指数和甘油三酯及γ-谷氨酰转移酶水平的算法)可在一个白人老年人群中准确识别经超声证实的 NAFLD。

相似文献

1
External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.基于人群的研究中评估脂肪肝指数识别非酒精性脂肪肝的外部验证。
Clin Gastroenterol Hepatol. 2013 Sep;11(9):1201-4. doi: 10.1016/j.cgh.2012.12.031. Epub 2013 Jan 22.
2
Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病的脂肪肝指数与腰围对比
World J Gastroenterol. 2016 Mar 14;22(10):3023-30. doi: 10.3748/wjg.v22.i10.3023.
3
Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese.中老年中国人非酒精性脂肪性肝病的脂肪肝指数验证
Medicine (Baltimore). 2015 Oct;94(40):e1682. doi: 10.1097/MD.0000000000001682.
4
Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.比较脂肪肝指数与非侵入性方法检测和定量脂肪变性。
World J Gastroenterol. 2013 Jan 7;19(1):57-64. doi: 10.3748/wjg.v19.i1.57.
5
Fatty liver index correlates with non-alcoholic fatty liver disease, but not with newly diagnosed coronary artery atherosclerotic disease in Chinese patients.脂肪肝指数与非酒精性脂肪性肝病相关,但与中国患者新诊断的冠状动脉粥样硬化性疾病无关。
BMC Gastroenterol. 2013 Jul 8;13:110. doi: 10.1186/1471-230X-13-110.
6
The fatty liver index is associated with increased mortality in subjects referred to coronary angiography.脂肪肝指数与接受冠状动脉造影检查的患者死亡率升高相关。
Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1231-8. doi: 10.1016/j.numecd.2013.02.004. Epub 2013 Apr 1.
7
A community-based study on the application of fatty liver index in screening subjects with nonalcoholic fatty liver disease.一项基于社区的研究,探讨脂肪肝指数在筛查非酒精性脂肪肝疾病患者中的应用。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):173-181. doi: 10.1016/j.jfma.2019.03.016. Epub 2019 Apr 11.
8
Fatty liver index and mortality: the Cremona study in the 15th year of follow-up.脂肪肝指数与死亡率:克雷莫纳研究的 15 年随访结果。
Hepatology. 2011 Jul;54(1):145-52. doi: 10.1002/hep.24356.
9
Role of Fatty Liver Index and Metabolic Factors in the Prediction of Nonalcoholic Fatty Liver Disease in a Lean Population Receiving Health Checkup.脂肪肝指数和代谢因素在体检瘦人群体中非酒精性脂肪肝预测中的作用。
Clin Transl Gastroenterol. 2019 May 22;10(5):1-8. doi: 10.14309/ctg.0000000000000042.
10
Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey.多民族的美国国家健康与营养检查调查中的脂肪肝指数
Aliment Pharmacol Ther. 2015 Jan;41(1):65-76. doi: 10.1111/apt.13012. Epub 2014 Nov 6.

引用本文的文献

1
Genetic Variants, Metabolic Dysfunction-Associated Fatty Liver Disease, and Major Health Outcomes in Older Adults.老年人中的基因变异、代谢功能障碍相关脂肪性肝病及主要健康结局
Biomedicines. 2025 Aug 14;13(8):1977. doi: 10.3390/biomedicines13081977.
2
Impact of metabolic dysfunction-associated steatotic liver disease on hepatocellular carcinoma risk in autoimmune hepatitis.代谢功能障碍相关脂肪性肝病对自身免疫性肝炎患者肝细胞癌风险的影响。
PLoS One. 2025 Jul 22;20(7):e0325066. doi: 10.1371/journal.pone.0325066. eCollection 2025.
3
Association of temporal MASLD with type 2 diabetes, cardiovascular disease and mortality.
颞叶代谢相关脂肪性肝病与2型糖尿病、心血管疾病及死亡率的关联
Cardiovasc Diabetol. 2025 Jul 15;24(1):289. doi: 10.1186/s12933-025-02824-3.
4
Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs.老年人脂肪性肝病:临床意义与未满足的需求
Nutrients. 2025 Jun 30;17(13):2189. doi: 10.3390/nu17132189.
5
Prevalence and outcomes of steatotic liver disease subtypes in older adults.老年人脂肪性肝病亚型的患病率及转归
Hepatol Commun. 2025 Jun 30;9(7). doi: 10.1097/HC9.0000000000000756. eCollection 2025 Jul 1.
6
Hyperuricemia-Especially "Metabolic Hyperuricemia"-Is Independently Associated with a Higher Risk of Steatotic Liver Disease.高尿酸血症——尤其是“代谢性高尿酸血症”——与脂肪性肝病的较高风险独立相关。
Metabolites. 2025 May 28;15(6):356. doi: 10.3390/metabo15060356.
7
Impact of type 2 diabetes on the risk of cardiovascular disease and cardiovascular mortality in patients with non-alcoholic fatty liver disease: a nationwide population-based study.2型糖尿病对非酒精性脂肪性肝病患者心血管疾病风险及心血管死亡率的影响:一项基于全国人口的研究。
BMJ Public Health. 2025 Jun 18;3(1):e002020. doi: 10.1136/bmjph-2024-002020. eCollection 2025.
8
Risk Heterogeneity of Liver-Related Events and Extrahepatic Outcomes Across MASLD Phenotypes and Risk Stratification by Liver Fibrosis.非酒精性脂肪性肝病(MAFLD)各表型中肝脏相关事件和肝外结局的风险异质性以及肝纤维化风险分层
Int J Endocrinol. 2025 Jun 1;2025:1262001. doi: 10.1155/ije/1262001. eCollection 2025.
9
Assessment of the diagnostic efficacy of five non-invasive tests for MASLD: external validation utilizing data from two cohorts.评估五种非侵入性检测方法对代谢相关脂肪性肝病(MASLD)的诊断效能:利用两个队列的数据进行外部验证
Front Nutr. 2025 May 22;12:1571487. doi: 10.3389/fnut.2025.1571487. eCollection 2025.
10
Associations Between MASLD, Ultra-Processed Food and a Mediterranean Dietary Pattern in Older Adults.老年人中代谢功能障碍相关脂肪性肝病、超加工食品与地中海饮食模式之间的关联
Nutrients. 2025 Apr 23;17(9):1415. doi: 10.3390/nu17091415.